Sarah T Thomas, Elizabeth T Thomas, Emily Schembri, Alexander C Lehn, David Dg Palmer
{"title":"Treatment outcomes in functional neurological disorder: a systematic review and meta-analysis exploring the influence of symptom chronicity.","authors":"Sarah T Thomas, Elizabeth T Thomas, Emily Schembri, Alexander C Lehn, David Dg Palmer","doi":"10.1136/bmjno-2025-001150","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Functional neurological disorder (FND) is a common cause of neurological disability with symptoms spanning motor, sensory and cognitive domains. While effective treatments exist, the impact of symptom chronicity on treatment outcomes is unclear. This systematic review and meta-analysis investigated whether longer symptom duration influences treatment outcomes across FND phenotypes: functional movement disorders, functional/dissociative seizures (FDS) and mixed presentations.</p><p><strong>Methods: </strong>MEDLINE, Embase, Cochrane Central Register of Controlled Trials, PsycINFO and grey literature were systematically searched till 29 June 2024. Studies were included if they involved adult FND participants undergoing any intervention and evaluated symptom change, function and health-related quality of life (HrQoL). Studies were excluded with <10 participants, missing symptom duration data or irrelevant outcomes. Two reviewers independently extracted data and assessed risk of bias. Meta-analyses used random effects models, subgroup analyses and univariate meta-regression to examine associations with symptom chronicity.</p><p><strong>Results: </strong>63 studies met inclusion criteria; 27 studies (885 participants) were meta-analysed. Longer symptom duration modestly reduced improvements in motor symptoms (-3.24 points/year, scale: 0-100) and physical HrQoL (-1.2 points/year, scale: 0-100). Global improvements (mean Clinical Global Impression-Change 2.43, 95% CI: 2.28 to 2.59, scale: 1-7) and mental HrQoL gains (mean Short Form-Mental Component Summary +5.04 points, 95% CI: 1.67 to 8.41) were observed irrespective of chronicity. FDS frequency reduced after psychotherapy in eight of nine studies, even with prolonged symptoms.</p><p><strong>Conclusions: </strong>Symptom chronicity modestly reduced motor and physical HrQoL improvements, but did not negate meaningful gains across a range of outcomes. Early diagnosis and treatment are critical for better outcomes, but remain beneficial in chronic stages.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"7 2","pages":"e001150"},"PeriodicalIF":2.4000,"publicationDate":"2025-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12506205/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Neurology Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjno-2025-001150","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Functional neurological disorder (FND) is a common cause of neurological disability with symptoms spanning motor, sensory and cognitive domains. While effective treatments exist, the impact of symptom chronicity on treatment outcomes is unclear. This systematic review and meta-analysis investigated whether longer symptom duration influences treatment outcomes across FND phenotypes: functional movement disorders, functional/dissociative seizures (FDS) and mixed presentations.
Methods: MEDLINE, Embase, Cochrane Central Register of Controlled Trials, PsycINFO and grey literature were systematically searched till 29 June 2024. Studies were included if they involved adult FND participants undergoing any intervention and evaluated symptom change, function and health-related quality of life (HrQoL). Studies were excluded with <10 participants, missing symptom duration data or irrelevant outcomes. Two reviewers independently extracted data and assessed risk of bias. Meta-analyses used random effects models, subgroup analyses and univariate meta-regression to examine associations with symptom chronicity.
Results: 63 studies met inclusion criteria; 27 studies (885 participants) were meta-analysed. Longer symptom duration modestly reduced improvements in motor symptoms (-3.24 points/year, scale: 0-100) and physical HrQoL (-1.2 points/year, scale: 0-100). Global improvements (mean Clinical Global Impression-Change 2.43, 95% CI: 2.28 to 2.59, scale: 1-7) and mental HrQoL gains (mean Short Form-Mental Component Summary +5.04 points, 95% CI: 1.67 to 8.41) were observed irrespective of chronicity. FDS frequency reduced after psychotherapy in eight of nine studies, even with prolonged symptoms.
Conclusions: Symptom chronicity modestly reduced motor and physical HrQoL improvements, but did not negate meaningful gains across a range of outcomes. Early diagnosis and treatment are critical for better outcomes, but remain beneficial in chronic stages.
背景:功能性神经障碍(FND)是一种常见的神经功能障碍,其症状跨越运动、感觉和认知领域。虽然存在有效的治疗方法,但症状的慢性性对治疗结果的影响尚不清楚。本系统综述和荟萃分析调查了更长症状持续时间是否会影响FND表型的治疗结果:功能性运动障碍、功能性/解离性癫痫(FDS)和混合表现。方法:系统检索MEDLINE、Embase、Cochrane Central Register of Controlled Trials、PsycINFO及灰色文献,检索截止至2024年6月29日。接受任何干预并评估症状改变、功能和健康相关生活质量(HrQoL)的成年FND参与者纳入研究。结果:63项研究符合纳入标准;27项研究(885名参与者)进行了荟萃分析。较长的症状持续时间适度降低了运动症状(-3.24分/年,评分范围:0-100)和身体HrQoL(-1.2分/年,评分范围:0-100)的改善。总体改善(平均临床总体印象-变化2.43,95% CI: 2.28至2.59,量表:1-7)和精神HrQoL的改善(平均短形式-精神成分总结+5.04分,95% CI: 1.67至8.41)与慢性无关。在9项研究中,有8项在心理治疗后FDS频率降低,即使症状延长。结论:慢性症状适度地降低了运动和身体HrQoL的改善,但并没有否定一系列结果的有意义的改善。早期诊断和治疗对于更好的结果至关重要,但在慢性阶段仍然有益。